Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TSL-1806 in Type 2 Diabetes Mellitus
CTR20211213Phase 2Completed
- Sponsor
- Tasly Pharmaceutical Group Co., Ltd.
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of LY2922470 in type 2 diabetes mellitus (T2DM), sponsored by Tasly Pharmaceutical Group Co., Ltd.. Started Jun 2021; status: completed.
02
Drugs
LY2922470
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20211213.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20211213.